Inhibition of Colony-Stimulating Factor-1 Receptor Enhances the Efficacy of Radiotherapy and Reduces Immune Suppression in Glioblastoma.

Almahariq, Muayad F; Quinn, Thomas J; Kesarwani, Pravin; Kant, Shiva; Miller, C Ryan; Chinnaiyan, Prakash

Almahariq, Muayad F; Quinn, Thomas J; Kesarwani, Pravin; Kant, Shiva; Miller, C Ryan; Chinnaiyan, Prakash.

Affiliation

Almahariq MF; Department of Radiation Oncology, Beaumont Health, Royal Oak, MI, U.S.A.
Quinn TJ; Department of Radiation Oncology, Beaumont Health, Royal Oak, MI, U.S.A.
Kesarwani P; Department of Radiation Oncology, Beaumont Health, Royal Oak, MI, U.S.A.
Kant S; Department of Radiation Oncology, Beaumont Health, Royal Oak, MI, U.S.A.
Miller CR; Division of Neuropathology, Department of Pathology, O'Neal Comprehensive Cancer Center, Comprehensive Neuroscience Center, University of Alabama School of Medicine, Birmingham, AL, U.S.A.
Chinnaiyan P; Department of Radiation Oncology, Beaumont Health, Royal Oak, MI, U.S.A.; prakash.chinnaiyan@beaumont.edu.

In Vivo ; 35(1): 119-129, 2021.

Article de En | MEDLINE | ID: mdl-33402457

Sujet(s)
Mots clés

CSF-1R; Glioblastoma; M2 macrophages; immunosuppression

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Glioblastome Type d'étude: Prognostic_studies Limites: Animals Langue: En Journal: In Vivo Sujet du journal: NEOPLASIAS Année: 2021 Type de document: Article Pays d'affiliation: États-Unis d'Amérique

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google